Literature DB >> 19949942

The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis.

J Paccou1, N Zeboulon, C Combescure, L Gossec, B Cortet.   

Abstract

Observational studies have indicated a high but heterogeneous prevalence of low bone mineral density for adult patients with cystic fibrosis. Fracture complications were also described. The objective of this study was to determine the prevalence of osteoporosis, osteopenia, and fractures among adult patients with cystic fibrosis. A systematic literature review was conducted using electronic databases. The keywords used were "cystic fibrosis [MeSH] AND bone density." Original studies were eligible if they reported the prevalence of osteoporosis and/or osteopenia and/or fractures in adult patients with cystic fibrosis. A meta-analysis of pooled proportions was performed. Heterogeneity was tested with the Cochran Q statistic, and in the case of heterogeneity a random effect model was used. Of 117 studies, 12 were selected, i.e., that represented a total of 1055 patients. Mean age ranged from 18.5 to 32 years (median: 28.2 years). Mean body mass index ranged from 19.9 to 22.4 (median: 20.7); 53.8% were men. The pooled prevalence of osteoporosis in adults with cystic fibrosis was 23.5% (95% CI, 16.6-31.0). The pooled prevalence of osteopenia was 38% (95% CI, 28.2-48.3). The pooled prevalences of radiological vertebral fractures and nonvertebral fractures were 14% (95% CI, 7.8-21.7) and 19.7% (95% CI, 6.0-38.8), respectively. In conclusion, this systematic literature review with meta-analysis emphasized the high prevalence of osteopenia and osteoporosis in young adults with cystic fibrosis. The prevalence of fracture was also high.

Entities:  

Mesh:

Year:  2009        PMID: 19949942     DOI: 10.1007/s00223-009-9316-9

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  27 in total

1.  Reduced bone volumetric density and weak correlation between infection and bone markers in cystic fibrosis adult patients.

Authors:  D Gensburger; S Boutroy; R Chapurlat; R Nove-Josserand; S Roche; M Rabilloud; I Durieu
Journal:  Osteoporos Int       Date:  2016-05-11       Impact factor: 4.507

2.  Why bother to take vitamins?

Authors:  Alison Morton
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

Review 3.  When Low Bone Mineral Density and Fractures Is Not Osteoporosis.

Authors:  Smita Jha; Marquis Chapman; Kelly Roszko
Journal:  Curr Osteoporos Rep       Date:  2019-10       Impact factor: 5.096

Review 4.  Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.

Authors:  J Jacquot; M Delion; S Gangloff; J Braux; F Velard
Journal:  Osteoporos Int       Date:  2015-10-02       Impact factor: 4.507

5.  Compromised bone microarchitecture and estimated bone strength in young adults with cystic fibrosis.

Authors:  Melissa S Putman; Carly E Milliren; Nicholas Derrico; Ahmet Uluer; Leonard Sicilian; Allen Lapey; Gregory Sawicki; Catherine M Gordon; Mary L Bouxsein; Joel S Finkelstein
Journal:  J Clin Endocrinol Metab       Date:  2014-06-13       Impact factor: 5.958

6.  Bone involvement in young adults with cystic fibrosis awaiting lung transplantation for end-stage respiratory failure.

Authors:  E Cairoli; C Eller-Vainicher; L C Morlacchi; P Tarsia; V Rossetti; M Pappalettera; M Arosio; I Chiodini; F Blasi
Journal:  Osteoporos Int       Date:  2019-02-23       Impact factor: 4.507

Review 7.  Endocrine Disorders in Cystic Fibrosis.

Authors:  Scott M Blackman; Vin Tangpricha
Journal:  Pediatr Clin North Am       Date:  2016-08       Impact factor: 3.278

Review 8.  Treatment of vitamin D deficiency in cystic fibrosis.

Authors:  Supavit Chesdachai; Vin Tangpricha
Journal:  J Steroid Biochem Mol Biol       Date:  2015-09-10       Impact factor: 4.292

Review 9.  Diagnosis and treatment of endocrine comorbidities in patients with cystic fibrosis.

Authors:  Oranan Siwamogsatham; Jessica A Alvarez; Vin Tangpricha
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

10.  Gastrointestinal Manifestations of Cystic Fibrosis.

Authors:  Sabina Sabharwal
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.